Anterix (NASDAQ:ATEX) Trading Up 5.1%

Anterix Inc. (NASDAQ:ATEXGet Rating)’s stock price was up 5.1% during trading on Friday . The stock traded as high as $33.39 and last traded at $32.71. Approximately 64,626 shares were traded during mid-day trading, a decline of 51% from the average daily volume of 132,010 shares. The stock had previously closed at $31.11.

Wall Street Analyst Weigh In

Separately, Morgan Stanley dropped their target price on shares of Anterix from $63.00 to $42.00 and set an “equal weight” rating for the company in a research report on Friday, February 24th.

Anterix Stock Performance

The company has a market capitalization of $604.94 million, a P/E ratio of -14.00 and a beta of 0.63. The firm’s fifty day moving average is $31.42 and its 200-day moving average is $33.02.

Insiders Place Their Bets

In related news, Chairman Morgan E. Obrien sold 45,000 shares of the business’s stock in a transaction on Monday, March 13th. The shares were sold at an average price of $30.04, for a total transaction of $1,351,800.00. Following the transaction, the chairman now owns 26,947 shares in the company, valued at approximately $809,487.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, CEO Robert Harris Schwartz purchased 2,500 shares of Anterix stock in a transaction that occurred on Thursday, March 9th. The stock was bought at an average price of $29.96 per share, for a total transaction of $74,900.00. Following the completion of the transaction, the chief executive officer now owns 101,373 shares in the company, valued at $3,037,135.08. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Chairman Morgan E. Obrien sold 45,000 shares of the stock in a transaction dated Monday, March 13th. The stock was sold at an average price of $30.04, for a total transaction of $1,351,800.00. Following the transaction, the chairman now owns 26,947 shares of the company’s stock, valued at approximately $809,487.88. The disclosure for this sale can be found here. Insiders own 3.53% of the company’s stock.

Institutional Investors Weigh In On Anterix

Institutional investors and hedge funds have recently modified their holdings of the company. JPMorgan Chase & Co. raised its stake in Anterix by 6.6% in the first quarter. JPMorgan Chase & Co. now owns 16,109 shares of the company’s stock valued at $532,000 after purchasing an additional 1,000 shares in the last quarter. State Street Corp boosted its holdings in Anterix by 2.7% in the first quarter. State Street Corp now owns 397,365 shares of the company’s stock valued at $13,129,000 after acquiring an additional 10,443 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Anterix by 3.5% during the 1st quarter. Geode Capital Management LLC now owns 379,648 shares of the company’s stock valued at $12,544,000 after buying an additional 12,757 shares in the last quarter. Deutsche Bank AG boosted its holdings in shares of Anterix by 48.7% during the 1st quarter. Deutsche Bank AG now owns 13,233 shares of the company’s stock valued at $437,000 after buying an additional 4,333 shares in the last quarter. Finally, CenterBook Partners LP raised its position in shares of Anterix by 14.1% in the 1st quarter. CenterBook Partners LP now owns 22,094 shares of the company’s stock worth $730,000 after purchasing an additional 2,734 shares during the last quarter. 83.53% of the stock is owned by hedge funds and other institutional investors.

About Anterix

(Get Rating)

Anterix, Inc operates as a wireless communications company. The firm focuses on commercializing spectrum assets to enable targeted utility and critical infrastructure customers to deploy private broadband networks, technologies and solutions. It’s solutions include Private LTE and Active Ecosystem. The company was founded by Peter Joel Lasensky and Richard Edward Rohmann in 1997 and is headquartered in Woodland Park, NJ.

Featured Stories

Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.